News: CVS Caremark Corp (CVS.N)

CVS.N on New York Stock Exchange

61.70USD
10:51am EDT
Price Change (% chg)

$-0.47 (-0.76%)
Prev Close
$62.17
Open
$61.96
Day's High
$61.96
Day's Low
$61.60
Volume
202,632
Avg. Vol
1,314,507
52-wk High
$62.22
52-wk Low
$43.65

Search Stocks
Select another date:
Photo

CVS Caremark set to pay $20 million to resolve SEC investigation

- CVS Caremark Corp said on Friday that it plans to pay a $20 million civil penalty to resolve a U.S. Securities and Exchange Commission investigation into 2009 comments and staff securities transactions and its accounting for an acquisition.

CVS Caremark set to pay $20 mln to resolve SEC investigation

Aug 2 - CVS Caremark Corp said on Friday that it plans to pay a $20 million civil penalty to resolve a U.S. Securities and Exchange Commission investigation into 2009 comments and staff securities transactions and its accounting for an acquisition.

Medicare patients do better taking drugs on time - study

June 27 - Americans on Medicare prescription drug plans do a better job of taking their medicines on time compared to other insured patients, and if more people followed their lead, it could save billions of dollars in healthcare costs, a report by CVS Caremark Corp concluded.

Haniel denies in talks with CVS to sell Celesio stake

DUESSELDORF, Germany - Diversified holding company Franz Haniel & Cie said on Wednesday it was not in talks with U.S. drugstore chain CVS to sell majority control over German drug distributor Celesio .

UPDATE 1-Haniel denies in talks with CVS to sell Celesio stake

* CVS prepared to pay Celesio 2 bln eur for stake -magazine

Haniel says not in talks with CVS to sell Celesio stake

DUESSELDORF, Germany, June 19 - Diversified holding company Franz Haniel & Cie on Wednesday said it was not in talks with U.S. group CVS to sell its 50.01 percent stake in German drug distributor Celesio, denying an earlier press report.

CVS Caremark profit rises, helped by generics, flu season

- CVS Caremark Corp posted a higher than expected first-quarter profit on Wednesday, helped by more profitable generic drugs on the market and a severe cold and flu season that boosted sales at its drugstores.

UPDATE 2-CVS Caremark profit rises, helped by generics, flu season

* CEO still confident can keep 60 pct of business won from Walgreen fight

BRIEF-CVS Caremark CEO says competiton for PBM contracts currently "competitive, yet rational"

May 1 - CVS Caremark Corp : * CEO says competiton for pbm contracts currently "competitive, yet rational" * CFO sees FY net revenue growth 1.75-3 percent * CFO sees FY net revenue growth 1.75-2.75 percent in pbm unit * CFO sees FY net revenue growth 2.25 percent-3.5 percent in retail pharmacy

BRIEF-CVS still "very confident" can keep 60 pct of scripts from Walgreen-Express Scripts spat

May 1 - CVS Caremark Corp : * Still "very confident" can keep at least 60 percent of scripts in 2013 gained

Select another date:
Search Stocks